Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to ...

The Nasdaq Biotechnology Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market ...

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel ...

Alvotech ( (ALVO) ) just unveiled an announcement.

The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to ...

Shares of Altimmune, Inc. climbed early on Thursday, recovering from a nearly 6% drop in the previous session, drawing ...

today announced its upcoming addition to the Nasdaq Biotechnology Index (Nasdaq: NBI) as part of the annual reconstitution of the 2024 Nasdaq index. Mesoblast’s inclusion in the NBI will be effective ...

has been selected to join the Nasdaq Biotechnology Index (NBI). The inclusion will be effective from the start of trading on December 23, 2024. The company, currently valued at approximately $530 ...

Spyre Therapeutics (SYRE) announced Spyre has been added to the Nasdaq Biotechnology Index effective prior to market open, Monday, December 23.

today announced that it will be added to the Nasdaq Biotechnology Index (NBI), effective at market open on Monday, December 23, 2024. “2024 has been a transformational year for MindMed.